1Anony Y.The university hospital consortium guidelines for the rise of albumin,nonproteincolloid,andcrystalloid solutions[J].Arch Intern Med,1995,155(4):373.
7Bar-Or D, Bar-Or R, Rael LT, et al. Heterogeneity and oxidation status of commercial albumin preparations in clinical use [J].Crit Care Med,2005,33(7) :1638-1641.
8Tanzi M,Gardner M,Megcllas M,et al. Evaluation of the appropriate use of albumin in adult and pediatric patients[J].Am J Health Syst Pharm ,2003,60( 13 ) : 1330-1335.
9Menon V, Greene T, Wang X, et al. C - rective protein and albumin predictors of all - cause and cardiovasular mortality in chronic kidney disease [ J ]. Kidney lnt ,2005,68 (2) :766.
10Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients systematic review of randomized controlled trials[J] . BMJ ,1988,317(7153) :235.
